#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypergammaglobulinaemia benign monoclonal Chemical burn Cervix carcinoma recurrent CDKL5 deficiency disorder Cutaneous T-cell lymphoma refractory Castleman's disease Optic glioma Adenomatous polyposis coli Erdheim-Chester disease Laryngeal squamous cell carcinoma Blood iron increased Squamous cell carcinoma of the oral cavity Small for dates baby Chronic myeloid leukaemia (in remission) Retinitis pigmentosa More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Trials in Disease Haemophilia A with anti factor VIII IgA nephropathy Bronchopulmonary dysplasia – Trials in Disease VEXAS syndrome Congenital hypotransferrinaemia – Diagnostics Alveolar rhabdomyosarcoma – Basic Information Epidermolysis bullosa – Treatment KBG syndrome – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-ARGININE Rasagiline INSULIN DEGLUDEC Dopamine Hydrochloride Triptorelin Pamoate Erlotinib Heparin Calcium Bendamustine Abt-494 Vortioxetine Hydrobromide Tirbanibulin Vigabatrin Sodium Ascorbate Resiquimod Sulfate Lixudebart Ds-3939A Povidone Mifepristone Fexofenadine Hydrochloride Levamisole Hydrochloride More therapies…

    Learn about Your Condition

    Precocious puberty Craniotomy Crohn's disease Arthritis infective Parkinson's disease Pleural mesothelioma Hereditary ataxia Small fibre neuropathy Eye pain Malignant peritoneal neoplasm Sleep disorder Rectal cancer recurrent Organ donor Meningorrhagia Complex regional pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Lyon Sud

Centre Hospitalier Lyon Sud

165 Chemin du Grand Revoyet, 69495 Pierre Bénite, Pierre Benite, 69495, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Radiotherapy Alone to Radiotherapy with Cisplatin for Patients with Sinus or Salivary Gland Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Cisplatin
    Belgium France

  • Study of Elranatamab for Patients with Multiple Myeloma Resistant to Proteasome Inhibitors, Immunomodulatory Drugs, and Anti-CD38 Antibodies

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Elranatamab
    Belgium France Germany Poland Spain

  • Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Daratumumab
    • Dexamethasone
    • Elranatamab
    Austria Belgium Czechia Finland France Germany +7

  • Study of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Carboplatin
    France

  • Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Elexacaftor
    • Ivacaftor
    • Tezacaftor
    Austria Belgium Czechia France Germany Hungary +7
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!